In focus
Latest feed
CXMT's Staggering Debut: A Chipmaker's Meteoric Rise Confirmed by First Earnings Report
Intuit's Fiscal Q4: A Look Beyond the Numbers at Growth and Strategic Direction
Invesco's Q2 2026: Navigating Growth and Income Fund Performance Alongside Record Corporate Milestones
Nektar Therapeutics Charts a Course Forward: Q2 2026 Sees Strategic Investment Amidst Financial Shifts
